320 related articles for article (PubMed ID: 30281842)
21. Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification.
Juan C; Bancroft AC; Choi JH; Nunez JH; Pagani CA; Lin YS; Hsiao EC; Levi B
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540768
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Al Mukaddam M; Pignolo RJ
Bone; 2018 Apr; 109():158-161. PubMed ID: 28600150
[TBL] [Abstract][Full Text] [Related]
23. A follow-up report on the published paper Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva.
Wallace H; Lee RH; Hsiao EC
Orphanet J Rare Dis; 2023 Mar; 18(1):61. PubMed ID: 36941608
[TBL] [Abstract][Full Text] [Related]
24. "I Can't Take off My Shirt or Do My Own Hair"-A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP).
Markowitz JT; Rofail D; Vandenberg G; Baldasaro J; Sanchez RJ; Pignolo RJ; Keen R; Davis M; Marquis P
Adv Ther; 2022 Jun; 39(6):2796-2805. PubMed ID: 35429282
[TBL] [Abstract][Full Text] [Related]
25. Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP).
Smilde BJ; Stockklausner C; Keen R; Whittaker A; Bullock AN; von Delft A; van Schoor NM; Yu PB; Eekhoff EMW
BMC Musculoskelet Disord; 2022 Jun; 23(1):519. PubMed ID: 35650602
[TBL] [Abstract][Full Text] [Related]
26. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
[TBL] [Abstract][Full Text] [Related]
27. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1
Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM
J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986
[TBL] [Abstract][Full Text] [Related]
28. The FOP Connection Registry: Design of an international patient-sponsored registry for Fibrodysplasia Ossificans Progressiva.
Mantick N; Bachman E; Baujat G; Brown M; Collins O; De Cunto C; Delai P; Eekhoff M; Zum Felde R; Grogan DR; Haga N; Hsiao E; Kantanie S; Kaplan F; Keen R; Milosevic J; Morhart R; Pignolo R; Qian X; di Rocco M; Scott C; Sherman A; Wallace M; Williams N; Zhang K; Bogard B
Bone; 2018 Apr; 109():285-290. PubMed ID: 28866367
[TBL] [Abstract][Full Text] [Related]
29. Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.
Pignolo RJ; Baujat G; Hsiao EC; Keen R; Wilson A; Packman J; Strahs AL; Grogan DR; Kaplan FS
J Bone Miner Res; 2022 Oct; 37(10):1891-1902. PubMed ID: 35854638
[TBL] [Abstract][Full Text] [Related]
30. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
de Ruiter RD; Smilde BJ; Pals G; Bravenboer N; Knaus P; Schoenmaker T; Botman E; Sánchez-Duffhues G; Pacifici M; Pignolo RJ; Shore EM; van Egmond M; Van Oosterwyck H; Kaplan FS; Hsiao EC; Yu PB; Bocciardi R; De Cunto CL; Longo Ribeiro Delai P; de Vries TJ; Hilderbrandt S; Jaspers RT; Keen R; Koolwijk P; Morhart R; Netelenbos JC; Rustemeyer T; Scott C; Stockklausner C; Ten Dijke P; Triffit J; Ventura F; Ravazzolo R; Micha D; Eekhoff EMW
Front Endocrinol (Lausanne); 2021; 12():732728. PubMed ID: 34858325
[TBL] [Abstract][Full Text] [Related]
31. Fibrodysplasia ossificans progressiva: Review and research activities in Japan.
Haga N; Nakashima Y; Kitoh H; Kamizono J; Katagiri T; Saijo H; Tsukamoto S; Shinoda Y; Sawada R; Nakahara Y
Pediatr Int; 2020 Jan; 62(1):3-13. PubMed ID: 31774601
[TBL] [Abstract][Full Text] [Related]
32. Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva.
Kou S; Kile S; Kambampati SS; Brady EC; Wallace H; De Sousa CM; Cheung K; Dickey L; Wentworth KL; Hsiao EC
Orphanet J Rare Dis; 2022 Mar; 17(1):107. PubMed ID: 35246171
[TBL] [Abstract][Full Text] [Related]
33. Fibrodysplasia ossificans progressiva in Brazil: challenges and strategies to create assistance and educational networks.
Zorzi AR; Delai PR; Rosa HLC; Brito WE; Montalli VAM; Napimoga JC; Napimoga MH; Nociti FH
Orphanet J Rare Dis; 2022 Sep; 17(1):348. PubMed ID: 36071499
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy in Fibrodysplasia Ossificans Progressiva: A Case Report and Systematic Review of the Literature.
Botman E; Netelenbos JC; Rustemeyer T; Schoonmade LJ; Nieuwenhuijzen JA; Teunissen BP; Visser M; Raijmakers P; Lammertsma AA; Dahele M; Eekhoff M
Front Endocrinol (Lausanne); 2020; 11():6. PubMed ID: 32117050
[TBL] [Abstract][Full Text] [Related]
35. A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton.
Kaplan FS; Glaser DL; Pignolo RJ; Shore EM
Expert Opin Biol Ther; 2007 May; 7(5):705-12. PubMed ID: 17477807
[TBL] [Abstract][Full Text] [Related]
36. Serum osteocalcin level is associated with the mortality in Chinese patients with Fibrodysplasia ossificans progressiva aged ≤18 years at diagnosis.
She D; Li R; Fang P; Zong G; Xue Y; Zhang K
BMC Musculoskelet Disord; 2020 Mar; 21(1):152. PubMed ID: 32143615
[TBL] [Abstract][Full Text] [Related]
37. Fibrodysplasia ossificans progressiva in China.
She D; Zhang K
Bone; 2018 Apr; 109():101-103. PubMed ID: 29175272
[TBL] [Abstract][Full Text] [Related]
38. [Genetic basis for skeletal disease. Establishment of novel treatments for fibrodysplasia ossificans progressiva (FOP)].
Katagiri T
Clin Calcium; 2010 Aug; 20(8):1204-11. PubMed ID: 20675931
[TBL] [Abstract][Full Text] [Related]
39. The Fibrodysplasia Ossificans Progressiva Physical Function Questionnaire (FOP-PFQ): A patient-reported, disease-specific measure.
Pignolo RJ; Kimel M; Whalen J; Kawata AK; Artyomenko A; Kaplan FS
Bone; 2023 Mar; 168():116642. PubMed ID: 36526263
[TBL] [Abstract][Full Text] [Related]
40. Disease aggravation following surgery in a rare patient suspected to Fibrodysplasia (Myositis) ossificans progressiva: a case report.
Zarei A; Rahimi F; Khadem M; Moradi M; Rahmani K
J Med Case Rep; 2023 Dec; 17(1):500. PubMed ID: 38044456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
